Clomid Dragon Pharma: Compound Profile
Clomiphene citrate is a selective estrogen receptor modulator (SERM) extensively studied in endocrinological research. This Dragon Pharma preparation provides researchers at Stroid UK Shop with a reliable analytical standard for investigating hypothalamic-pituitary-gonadal axis modulation. The compound functions as a competitive antagonist at hypothalamic estrogen receptors while demonstrating agonist activity in peripheral tissues, making it valuable for researchers examining tissue-selective estrogen receptor interactions.
Laboratory Research Applications
Research institutions utilise clomiphene citrate to study gonadotropin release mechanisms and estrogen receptor pharmacology. The compound’s dual mechanism allows investigators to examine both antagonistic effects at central nervous system estrogen receptors and agonistic activity in bone tissue models. Scientists studying reproductive endocrinology frequently incorporate this SERM into their research protocols when investigating luteinising hormone and follicle-stimulating hormone regulation. Researchers exploring clomiphene citrate compounds often compare its selectivity profile with other research chemicals available through SARM investigations and peptide research to understand receptor-specific modulation patterns.
Analytical Specifications
| Parameter | Value |
|---|---|
| CAS Registry | 50-41-9 |
| Molecular Formula | C₃₂H₃₆ClNO₈ |
| Molecular Weight | 598.08 g/mol |
| Classification | Selective Estrogen Receptor Modulator |
| Manufacturer | Dragon Pharma |
| Research Grade | Analytical Standard |
Research Use Compliance
This product is manufactured exclusively for in-vitro laboratory research and analytical testing purposes. Not approved for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure compliance with institutional protocols and local regulations governing SERM research compounds.
